ALEXANDER MARGARET A. 4
4 · Ovid Therapeutics Inc. · Filed Feb 24, 2025
Insider Transaction Report
Form 4
ALEXANDER MARGARET A.
DirectorPresident and CEO
Transactions
- Award
Common Stock
2025-02-20+43,750→ 78,685 total - Award
Employee Stock Option (Right to Buy)
2025-02-20+262,500→ 262,500 totalExercise: $0.57Exp: 2035-02-19→ Common Stock (262,500 underlying)
Footnotes (3)
- [F1]Represents a restricted stock unit ("RSU") award. The RSUs will vest in three equal annual installments commencing on February 22, 2026, subject to the Reporting Person's continuous service through each such vesting date.
- [F2]Each RSU represents a contingent right to receive one share of Common Stock.
- [F3]The shares subject to the stock option will vest in 48 equal monthly installments commencing on March 20, 2025, subject to the Reporting Person's continued services through each such date.